Three US Banks Positioned for the Rate and Capital Markets Recovery
BAC offers NIM expansion at 12.3x forward earnings, JPM delivers 21% ROTCE at 12.7x, and Goldman's IB pipeline recovery at 13.8x could drive 25-30% upside.
BAC trades at 13.8x earnings — a 25% discount to JPMorgan — despite posting a 41.6% operating margin and $30.5 billion in net income. The discount is a mispricing, and the $40 billion trading quarter is about to prove it.
Bank of America trades at 13.8x trailing earnings. JPMorgan trades at 15.5x. Goldman Sachs at 17.7x. That discount — roughly 15-25% depending on the peer — has persisted for over a year despite BAC posting a 41.6% operating margin, $30.5 billion in net income, and a 2.05% dividend yield.
The market's logic is that BAC is a rate-sensitive, consumer-heavy bank with less trading upside than Goldman and less franchise dominance than JPMorgan. That logic was reasonable in 2023. It's wrong today.
BAC's Merrill Lynch and BofA Securities divisions have been quietly gaining share in equities trading and fixed income. The $40 billion trading quarter reportedly heading Wall Street's way will not be concentrated at Goldman and JPM alone. BAC's share of that windfall could surprise to the upside, and at 13.8x, none of it is priced in.
BAC returned over $16 billion to shareholders in 2025 through dividends and buybacks. The $0.26 quarterly dividend, while modest on a per-share basis, represents a 44% payout ratio — conservative enough to allow for increases while maintaining a fortress capital ratio.
The buyback programme has been the more interesting capital allocation lever. BAC has been repurchasing shares at prices well below the current $52.56, which means the programme has been genuinely accretive to per-share earnings. This is capital allocation done right — buying back stock when the market undervalues it, not when it's expensive and the board feels pressure to "return capital."
Across three decades of banking cycles, the pattern is consistent: banks that buy back stock aggressively during periods of valuation compression — like BAC at 13.8x today — generate outsized shareholder returns over the subsequent 3-5 years. Citigroup missed this opportunity in 2010-2012. BAC isn't making the same mistake.
The 2.05% dividend yield provides income while you wait. It's not flashy, but combined with the buyback and a P/E that has room to expand, the total return profile is attractive.
TickerXray Report
Get the complete Bank of America report with all 12 quantitative models, AI-generated investment thesis, and real-time data.
The $377 billion market cap is supported by $191.6 billion in revenue and $30.5 billion in net income — a 15.9% net margin that has been improving steadily. The operating margin of 41.6% is the highest among the Big Four banks.
Earnings per share of $3.81 at a $52.56 stock price gives the 13.8x multiple. The consensus target of $52.38 implies essentially zero upside — analysts are pricing BAC for stagnation. That consensus target looks stale given the trading environment.
The beta of 1.38 means BAC will move with conviction in either direction. In a risk-on environment driven by Iran de-escalation or strong bank earnings this week, BAC has more torque than JPM (beta 1.04) or GS (beta 1.25). The 52-week range of $36.98 to $56.00 shows the stock can move 30%+ in a single year. We think the next 30% move is up, not down.
Bears point to BAC's consumer lending exposure as a risk in an economic slowdown. Credit card delinquencies are ticking up, auto loan defaults are rising, and mortgage origination volumes remain depressed. All true. But consumer credit costs are manageable — BAC's provision for credit losses is well-funded, and the bank stress-tested its portfolio against scenarios far worse than the current environment. A mild recession doesn't break this bank. A severe recession doesn't break this bank either — it just slows the earnings growth for a few quarters.
Bank of America at 13.8x earnings is a mispricing. The market is treating BAC as a rate-sensitive consumer bank while ignoring the institutional franchise, the capital return programme, and the trading tailwind heading into earnings this week.
We're buyers at current levels with a 12-month target of $62-65, representing a re-rating to 16-17x earnings. The catalyst is this week's earnings — if BAC posts a trading beat alongside healthy NII guidance, the discount to JPM starts to close. At $65, BAC would still trade cheaper than JPM on every relevant metric. The margin of safety at $52 is meaningful.
Full forensic analysis of Bank of America
+ 6 more models included
150,000+ stocks covered
Global coverage across 60+ exchanges. Every report includes all 12 quantitative models and AI analysis.
View plansEvery report runs 12 quantitative models and generates an AI investment thesis. From Piotroski scores to manipulation detection -- get the full picture in seconds.
12 forensic models
Piotroski, Altman, Beneish, DuPont & more
AI investment thesis
Synthesized outlook on every stock
Manipulation detection
Spot red flags before they hit the news
150,000+ tickers
Global coverage across 60+ exchanges
Expected return
Forward return projections for every stock
Real-time data
Live prices, insider trades, news sentiment
Free accounts get 1 report per month. Pro gets unlimited.
BAC offers NIM expansion at 12.3x forward earnings, JPM delivers 21% ROTCE at 12.7x, and Goldman's IB pipeline recovery at 13.8x could drive 25-30% upside.
BAC trades at 13x forward earnings while growing net interest income at 12% annually. Management just flagged international expansion as the next growth lever — the market yawned.
Costco's membership model is exceptional. At 51.8x trailing earnings — the most expensive large-cap retailer on earth — the capital allocation math no longer works, even for a company this good.